Fig. 7: LIMD1-AS1 reversed THZ1-mediated the growth inhibition of glioma cells.
From: Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
A Expression of LIMD1-AS1 in patient-derived glioblastoma cells. B Expression of LIMD1-AS1 in PN12 and PN16 treated with Control or THZ1. **P < 0.01. C, D The migration of PN12 and PN16 cells treated with Control or THZ1. **P < 0.01. E, F The invasion of PN12 and PN16 cells was treated with Control or THZ1 at an indicated concentration. **P < 0.01. G, H The migration of PN12 and PN16 cells with THZ1 treatment following transfected with LIMD1-AS1 plasmid. **P < 0.01 vs. vector, ##P < 0.01 vs. THZ1. I, J The invasion of PN12 and PN16 cells with THZ1 treatment following transfected with LIMD1-AS1 plasmid. **P < 0.01 vs. vector, ##P < 0.01 vs. THZ1.
